RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Cedars-Sinai Accelerator
C

Cedars-Sinai Accelerator portfolio

Cedars-Sinai Accelerator has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Tasso's $100M Series B+ round in December 2021, alongside SIB Innovations- und Beteiligungsgesellschaft, Senvest Management, RA Capital Management and 6 others. That company is in Health and bio. It has co-invested with Foresite Capital, Merck Global Health Innovation Fund and RA Capital Management, most often Foresite Capital (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $117M.
Latest deal: Tasso · Dec 16, 2021.

What Cedars-Sinai Accelerator invests in

How Cedars-Sinai Accelerator invests

StageDealsCapital in rounds
Series B+ 1 50%$100M
Series A 1 50%$17M
YearDealsCapital in rounds
2020 1 50%$17M
2021 1 50%$100M

Share is of the 2 rounds on Recent Funding that name Cedars-Sinai Accelerator. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Cedars-Sinai Accelerator portfolio companies

CompanyRound with Cedars-Sinai AcceleratorTotal raisedLatest raise
TTasso
Health and bio
Series B+ · $100M$123.1MDec 16, 2021
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Cedars-Sinai Accelerator, which is a subset of its real portfolio. API: /api/v1/investors/cedars-sinai-accelerator (get a free API key). More: the most active VC firms and new venture capital funds.